Millions of people have used weight loss drugs such as Ozempic and Mounjaro in the past year — but a new study suggests that lifestyle benefits may not extend much further than the number on the scale.
Published in The BMJ, the study analysed 262 clinical trials involving around 100,000 participants and 19 different drugs.
